Showing results (31-40 of 711) with videos related to

Sort By:
Pageof 72
Frontiers in Medicine|July 5, 2022
Hepatitis C Prevalence, Incidence, and Treatment in Chinese Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study-China (2019-21)Liangying Gan, Dongyu Wang, Brian Bieber, et al.
Seminars in Dialysis|September 22, 2021
Blood flow rate: An independent risk factor of mortality in Chinese hemodialysis patientsXinju Zhao, Qingyu Niu, Liangying Gan, et al.
Drugs in R&D|April 5, 2022
Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate in Chinese Subjects with and without Hemodialysis-Dependent Stage 5 Chronic Kidney DiseaseLiangying Gan, Panpan Xie, Yan Tan, et al.
Scientific Reports|January 14, 2021
Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS)Xinju Zhao, Qingyu Niu, Liangying Gan, et al.
European Journal of Clinical Pharmacology|June 17, 2022
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysisLingxiao Zhang, Liangying Gan, Kexin Li, et al.
Renal Failure|July 20, 2025
Analysis of red blood cell lifespan and associated influencing factors in anemic dialysis patientsJiaqing Wu, Bei Wu, Weili Gao, et al.
Frontiers in Psychology|October 25, 2021
The Implementation of Patient-Centered Humanistic Care for COVID-19 Closely Contacted Hemodialysis Patients Under the Hospital-Based Group Medical Quarantine: A Brief Research ReportHe Zhang, Liangying Gan, Xiaodan Li, et al.
Renal Failure|May 5, 2026
Performance-based classification of dialyzers: integrating YKL-40 for advanced middle-molecule clearance - A Chinese expert consensusLi Zhu, Liangying Gan, Yuankai Xu, et al.
Clinical Kidney Journal|January 8, 2024
Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trialLiangying Gan, Li Xing, Yan Xu, et al.
Frontiers in Medicine|August 5, 2022
Application of Angiotensin Receptor-Neprilysin Inhibitor in Chronic Kidney Disease Patients: Chinese Expert ConsensusLiangying Gan, Xiaoxi Lyu, Xiangdong Yang, et al.
Pageof 72